The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cannabis infused edible products market is expected to exhibit a CAGR of 15.2% during 2022-2027.
Cannabis-infused edible products include food and beverages that contain cannabinoid drugs extracted from the Cannabis Sativa plant. These drugs can be primarily classified into tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is a psychoactive ingredient that is precisely used for medical purposes, whereas CBD is a non-psychoactive component used in both non-medical and medical applications. Cannabis-infused edible products are considered to be a healthier alternative to smoking cannabis as they reduce the exposure to carbon, tar, and carcinogens. These products are widely adopted for treating insomnia, inflammation, chronic pain, depression, anxiety, hyperemesis, etc. Cannabis-infused edible products mainly include chocolates, brownies, cookies, tea, snacks, spreads, pills, gummies, etc.
The rising aversion towards smoking cannabis coupled with the growing health concerns regarding the high prevalence of respiratory ailments is primarily driving the demand for cannabis-infused edible products. Furthermore, the increasing legalization of recreational cannabis across countries, such as the United States, Canada, Argentina, Netherlands, Spain, etc., is also propelling the market growth. The rising consumer awareness towards several health benefits of cannabis-infused edible products in treating poor appetite and weight loss in cancer patients, minimizing pain and muscle spasms, and relieving nausea, is further augmenting the market. Moreover, the wide availability of cannabis-infused edibles through legal marijuana dispensaries has bolstered the sales of cannabis cola, fruit punch, coffee, and other beverages. Apart from this, the increasing utilization of hemp and cannabidiol in pet food products for treating epilepsy, osteoporosis, anxiety, joint pain, etc., is also positively influencing the global market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cannabis infused edible products market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and distribution channel.
Breakup by Product Type:
Breakup by Distribution Channel:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Baked Bros, Bhang Corp., Botanic Lab, Cannabinoid Creations, Canopy Growth Corporation, Charlotte's Web, Dixie Brands Inc., Grön Confections., Kats Botanicals, Kaya Holdings Inc., Kiva Confections, Koios Beverage Corp., Lord Jones (Zeus Cannabinoids, LLC) and Medix CBD (CBD Capital Group).
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Baked Bros, Bhang Corp., Botanic Lab, Cannabinoid Creations, Canopy Growth Corporation, Charlotte's Web, Dixie Brands Inc., Grön Confections., Kats Botanicals, Kaya Holdings Inc., Kiva Confections, Koios Beverage Corp., Lord Jones (Zeus Cannabinoids, LLC) and Medix CBD (CBD Capital Group)|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at